
Bioxytran Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Bioxytran Inc
Access all reports
Bioxytran Inc. is a biotechnology company focused on developing therapies for fibrotic and viral diseases. The company specializes in glycovirology, using carbohydrate-based drugs to target viral infections and inflammatory conditions. Its research includes treatments for diseases such as COVID-19 and pulmonary fibrosis, aiming to improve oxygen delivery and tissue regeneration. The company is headquartered in Needham, Massachusetts, and its shares are listed on the OTCQB.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
BIXT
Country
πΊπΈ United States